Science Explorer Back to mapMap
Discussion
Researcher · Iwakuni Medical Center · Japan

Shoichi Kuyama

Shoichi Kuyama publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0002-6079-3511 OpenAlex
World rank
#2,842,256
of 7,710,434 ranked researchers
Rank in Japan
#61,595
of 383,136
Works
205
Citations
4.5k
Citations per work
22.1
h-index
21
i10-index 43Top 18% in Pulmonary and Respiratory Medicine
Shoichi Kuyama

What does Shoichi Kuyama research?

Shoichi Kuyama's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 148 works · 72.1% of their workMedicine: 148 works · 72.1% of their workPulmonary and Respiratory Medicine: 83 works · 40.5% of their workOncology: 54 works · 26.2% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 2.7% of their workSurgery: 6 works · 2.7% of their workEverything else: 42 works · 20.6% of their workLife Sciences: 15 works · 7.3% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 7.3% of their workMolecular Biology: 9 works · 4.6% of their workCancer Research: 6 works · 2.7% of their workTHEIR WORKShoichi Kuyama205works
Life Sciences7%Health Sciences72%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine14872.1%
  2. Everything else4220.6%
    1. Biochemistry, Genetics and Molecular Biology157.3%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology26% of their works
  3. 3Molecular Biology5% of their works
  4. 4Surgery3% of their works
  5. 5Cancer Research3% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Shoichi Kuyama's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy1853 topics
  2. Clinical Trials1722 topics
  3. Chemotherapy1284 topics
  4. ALK Inhibitors1141 topic
  5. EGFR Mutations1141 topic
  6. Genomic Profiles581 topic
  7. Small-Cell Lung Cancer581 topic
  8. CT Screening381 topic
  9. Lung Cancer381 topic
  10. Immune Checkpoint Blockade231 topic
  11. PD-1 and PD-L1231 topic
  12. Cetuximab211 topic
  13. KRAS Mutations211 topic
  14. Cancer Genomics131 topic
  15. Fibrosis131 topic
  16. Idiopathic Pulmonary Fibrosis131 topic
  17. Mutational Signatures131 topic
  18. DNA111 topic
  19. Topoisomerases111 topic

Where does Shoichi Kuyama work?

Shoichi Kuyama's main affiliation in the publication record is Iwakuni Medical Center, Japan.

How many publications and citations does Shoichi Kuyama have?

OpenAlex counts 205 works and 4,529 citations for Shoichi Kuyama, an h-index of 21, ranking #2,842,256 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shoichi Kuyama. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.